Key File


5 Day -0.29%
1 Month 10.06%
3 Month -19.48%
YTD -5.83%
1 Year -9.12%



Genetic Technologies Ltd. ADR

Genetic Technologies Ltd. is a molecular diagnostics company that uses predictive testing and assessment tools to help doctors proproactively manage women's health. It opeprices via the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breastern cancer. The firm was established on January 5, 1987 and also is headquartered in Fitzroy, Australia.

You are watching: American gene technologies stock


Name Chg % Market Cap
Quest Diagnostics Inc. -0.15% $18.91B
Thermo Fisher Scientific Inc. 6.49% $234.79B
Laboratory Corp. of America Holdings -0.30% $28.62B
Neogen Corp. -1.15% $4.45B
Rosetta Genomics Ltd. 66.67%
Compugen Ltd. 9.28% $563.29M
Myriad Genetics Inc. 3.37% $2.63B
Danaher Corp.

See more: Future Made Myself A Boss - Made Myself A Boss (Testo)

0.16% $231.68B

By utilizing this website you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and also Cookie Notice ().

Intraday Data detailed by FACTSET and topic to terms of use. Historical and also current end-of-day data noted by FACTSET. All quotes are in regional exadjust time. Real-time last sale data for UNITED STATE stock quotes reflect trades reported via Nasdaq only. Intraday information delayed at least 15 minutes or per exadjust requirements.

This web browser is no longer supported at For the best experience, please update to a modern-day web browser.